WallStreetZenWallStreetZen

NASDAQ: FOLD
Amicus Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for FOLD

Based on 4 analysts offering 12 month price targets for Amicus Therapeutics Inc.
Min Forecast
$15.00+42.31%
Avg Forecast
$19.00+80.27%
Max Forecast
$22.00+108.73%

Should I buy or sell FOLD stock?

Based on 4 analysts offering ratings for Amicus Therapeutics Inc.
Strong Buy
Strong Buy
3 analysts 75%
Buy
0 analysts 0%
Hold
1 analysts 25%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their FOLD stock forecasts and price targets.

FOLD stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-18
lockedlocked$00.00+00.00%2024-02-29
lockedlocked$00.00+00.00%2023-12-19Find Out Why
lockedlocked$00.00+00.00%2023-11-09

1 of 1

Forecast return on equity

Is FOLD forecast to generate an efficient return?
Company
N/A
Industry
-74.7%
Market
19.57%

Forecast return on assets

Is FOLD forecast to generate an efficient return on assets?
Company
N/A
Industry
7.45%

FOLD revenue forecast

What is FOLD's revenue in the next 3 years based on estimates from 5 analysts?
Avg 1 year Forecast
$528.3M+32.28%
Avg 2 year Forecast
$659.6M+65.16%
Avg 3 year Forecast
$773.9M+93.78%
FOLD's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

FOLD revenue growth forecast

How is FOLD forecast to perform vs Biotechnology companies and vs the US market?
Company
28.07%
Industry
59.26%
Market
9.23%
FOLD's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
FOLD's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

FOLD vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
FOLD$10.54$19.00+80.27%Strong Buy
BHVN$38.72$55.57+43.52%Strong Buy
SWTX$43.38$66.60+53.53%Strong Buy
CRNX$43.32$57.89+33.63%Strong Buy
XENE$39.50$59.50+50.63%Strong Buy
View Top Biotech Stocks

Amicus Therapeutics Stock Forecast FAQ

Is Amicus Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: FOLD) stock is to Strong Buy FOLD stock.

Out of 4 analysts, 3 (75%) are recommending FOLD as a Strong Buy, 0 (0%) are recommending FOLD as a Buy, 1 (25%) are recommending FOLD as a Hold, 0 (0%) are recommending FOLD as a Sell, and 0 (0%) are recommending FOLD as a Strong Sell.

If you're new to stock investing, here's how to buy Amicus Therapeutics stock.

What is FOLD's revenue growth forecast for 2024-2026?

(NASDAQ: FOLD) Amicus Therapeutics's forecast annual revenue growth rate of 28.07% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 59.26%, and while it is forecast to beat the US market's average forecast revenue growth rate of 9.23%.

Amicus Therapeutics's revenue in 2024 is $399,356,000.On average, 5 Wall Street analysts forecast FOLD's revenue for 2024 to be $156,045,318,089, with the lowest FOLD revenue forecast at $150,967,690,954, and the highest FOLD revenue forecast at $161,692,442,904. On average, 5 Wall Street analysts forecast FOLD's revenue for 2025 to be $194,831,713,751, with the lowest FOLD revenue forecast at $185,647,972,899, and the highest FOLD revenue forecast at $203,598,374,352.

In 2026, FOLD is forecast to generate $228,587,743,496 in revenue, with the lowest revenue forecast at $227,527,319,912 and the highest revenue forecast at $229,648,167,080.

What is FOLD's forecast return on assets (ROA) for 2024-2026?

(NASDAQ: FOLD) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 7.45%.

What is FOLD's Price Target?

According to 4 Wall Street analysts that have issued a 1 year FOLD price target, the average FOLD price target is $19.00, with the highest FOLD stock price forecast at $22.00 and the lowest FOLD stock price forecast at $15.00.

On average, Wall Street analysts predict that Amicus Therapeutics's share price could reach $19.00 by Mar 18, 2025. The average Amicus Therapeutics stock price prediction forecasts a potential upside of 80.27% from the current FOLD share price of $10.54.

What is FOLD's forecast return on equity (ROE) for 2024-2026?

(NASDAQ: FOLD) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.